Synthesis and cis–trans isomerism in novel Leu-enkephalin-related peptidomimetics containing N-glycated glycine residues

Abstract

The influence of a new peptoid residue on amide-bond stereochemistry has been explored via the synthesis and NMR analysis of novel peptidomimetics related to the endogenous opioid pentapeptide Leu-enkephalin (H-Tyr-Gly-Gly-Phe-Leu-OH). The compounds studied include protected and unprotected enkephalin analogues N-alkylated at either the second (Gly²) or both the second and the third (Gly²,Gly³) amino acid residues with a 6-deoxy-D-galactose moiety. The syntheses of the mono- (7) and the bis-glycated pentapeptide (11) were performed in a stepwise manner in solution by employing N-glycated glycine as the building block. The relative populations of the cis and trans isomers in the compounds studied were estimated by NMR spectroscopy. In the fully protected N-glycated dipeptide 3 the most abundant isomer (64%) was shown to contain a cis Tyr¹-(X)Gly² amide bond. NMR analysis of mono-N-glycated pentapeptide 6 provided evidence that elongation of the peptide chain disfavours the cis and augments the trans isomer population (cis∶trans 35∶65). For the unprotected monoglycated peptides 5 and 7 both the α- and β-pyranose forms of the galactose moieties were detected, the β-pyranose tautomer being the most abundant (≈70%). Removal of the protecting groups decreased the proportion of cis-rotamers relative to the corresponding protected peptides 3 and 6. The NMR spectra of enkephalin-related peptides 8–11, which contain two N-glycated glycine residues, were extremely complex; both proximal and distal isomerization effects were observed. For the bis-glycated tripeptide 8 significant amounts of both the cis and trans rotamers were observed for the Tyr¹-(X)Gly² and (X)Gly²-(X)Gly³ peptide bonds. In the fully protected pentapeptide 10 the configurational equilibrium was markedly shifted in favour of the trans isomers; only 15% of the cis isomer was observed for the Tyr¹-(X)Gly² bond, whereas the (X)Gly²-(X)Gly³ bond was completely in the trans configuration.

References

1. G. A. Olson, R. D. Olson and A. J. Kastin, Peptides, 1996, 17, 1421.
2. P. W. Schiller, in Medicinal Chemistry for the 21st Century, ed. C. G. Wermuth, N. Koga, H. König and B. W. Metcalf, Blackwell, Oxford, IUPAC, 1992, pp. 215–232.
3. M. Skurić, J. Horvat, Š. Horvat, N. N. Chung and P. W. Schiller, Int. J. Pept. Protein Res., 1994, 43, 402 and references cited therein.
4. Š. Horvat, M. Roščić, L. Varga-Defterdarović and J. Horvat, J. Chem. Soc., Perkin Trans. 1, 1998, 909.
5. R. Polt, F. Porreca, L. Z. Szabo, E. J. Bilsky, P. Davis, T. J. Abbruscato, T. P. Davis, R. Horvath, H. I. Yamamura and V. J. Hruby, Proc. Natl. Acad. Sci. USA, 1994, 91, 7114.
6. E. G. von Roedern, E. Lohof, G. Hessler, M. Hoffmann and H. Kessler, J. Am. Chem. Soc., 1996, 118, 10 156.
7. B. Drouillat, B. Kellam, G. Dekany, M. S. Starr and I. Toth, Bioorg. Med. Chem. Lett., 1997, 7, 2247.
8. A. Jakas and Š. Horvat, J. Chem. Soc., Perkin Trans. 2, 1996, 789.
9. Š. Horvat, A. Jakas, E. Vass, J. Samu and M. Hollósi, J. Chem. Soc., Perkin Trans. 2, 1997, 1523.
10. J. Rhodes, B. Zheng and C. A. Morrison, Ann. N.Y. Acad. Sci., 1995, 754, 169.
11. R. Carubelli, Experientia, 1995, 51, 121.
12. R. E. Arrick, D. C. Baker and D. Horton, Carbohydr. Res., 1973, 26, 441.
13. J. Coste, E. Frérot and P. Jouin, J. Org. Chem., 1994, 59, 2437.
14. P. Dais and A. S. Perlin, Carbohydr. Res., 1987, 169, 159.
15. S. J. Angyal, Carbohydr. Res., 1994, 263, 1.
16. B. Vitoux, A. Aubry, M. T. Cung and M. Marraud, Int. J. Pept. Protein Res., 1986, 27, 617.
17. T. Ozawa, Y. Isoda, H. Watanabe, T. Yuzuri, H. Suezawa, K. Sakakibara and M. Hirota, Magn. Reson. Chem., 1997, 35, 323.
18. M. Nishio, Y. Umezawa, M. Hirota and Y. Takeuchi, Tetrahedron, 1995, 51, 8665.